Clinical Orthopaedics and Related Research: December 2013 - Volume 471 - Issue 12 - p 3830–3837 doi: 10.1007/s11999-013-2926-6 Symposium: 2012 International Hip Society Proceedings

No Difference in Gait Recovery After THA With Different Head Diameters: A Prospective Randomized Study

Zagra, Luigi, MD1; Anasetti, Federica, MSEng2; Bianchi, Luca, MD1, a; Licari, Vittorio, MD3; Ceroni, Roberto, Giacometti, MD1
Hip

Background Larger femoral heads are commonly presumed to improve joint stability and hip biomechanics; some studies have suggested they may hasten recovery of a normal gait. To our knowledge, no gait analysis studies have compared different size head diameters in THA.

 

Questions/purposes We compared (1) spatiotemporal gait parameters, (2) kinematic and kinetic gait parameters, and (3) Harris hip scores in patients undergoing THA randomized to receive a 28-, 36-, or ≥ 42-mm bearing couple. We hypothesized a larger femoral head would restore an earlier, more physiologic gait pattern.

 

Methods This randomized, blinded study involved 60 patients who received the same cementless THA except for the size of the bearing. Inclusion criteria were primary hip arthritis, female sex, and age between 55 and 70 years. Exclusion criteria were other problems influencing walking ability. The patients were randomized into three groups of 20 each (28- and 36-mm ceramic-on-crosslinked polyethylene, ≥ 42-mm metal-on-metal). All patients underwent the same postoperative rehabilitation protocol. Gait evaluation using an optoelectronic system was performed preoperatively and at 2 and 4 months postoperatively.

 

Results With the numbers available, no differences in spatiotemporal gait parameters, kinematic or kinetic gait parameters, or Harris hip scores emerged among the three groups. All variables assessed at 4 months postoperatively showed improvements across all groups, but the differences among them were not significant.

 

Conclusions The hypothesis that a larger femoral head results in improved early gait performance was not supported by this study.

 

Level of Evidence Level I, therapeutic study. See Instructions for Authors for a complete description of levels of evidence.


Download article